Clinical Performance of Capillary Blood Samples Collected Using the Tasso+ Serum Gel Capillary Blood Collection System for Clinical Chemistry Testing of 14 Analytes on an Abbott Alinity Analyzer
Part of paid clinical trials in Atlantis, Florida.
- Sponsor
- Tasso Inc.
- Study ID
- NCT07260799
- Status
- Recruiting
Conditions
- Serum Analytes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Accepted
Interventions
- Tasso+ Serum Gel Capillary Blood Collection System — DIAGNOSTIC_TESTClinical evaluation of capillary blood samples collected using the Tasso+ Serum Gel Capillary Blood Collection System for downstream analyte testing.
Study Details
The purpose of this single-visit study is to demonstrate the performance of capillary blood samples collected with the Tasso+ Serum Gel Capillary Blood Collection System compared to venous reference samples for downstream analyte testing at a clinical laboratory.
Key Dates
- Start date
- Oct 25, 2025
- Status verified
- Mar 2026
- Primary completion
- May 31, 2026
- Completion
- May 31, 2026
Study Design
- Enrollment
- 150 participants (estimated)
Arms
- Arm: Tasso+ Serum Gel Capillary Blood Collection SystemComparison of serum analyte results from capillary blood collected using the Tasso+ Serum Gel Capillary Blood Collection System vs. venous blood obtained via traditional venipuncture.
Primary Outcome Measure
Number participants for which there is statistical equivalence between serum biomarker results obtained from capillary blood vs. venous blood [ Time Frame: 48 Hours ]
Central Contacts
- DEMA POPPA, MS(206) 822-4186
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Celesta / American Research Labs | Atlantis | Florida | 33462 | Sri Madireddy, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Atlantis, FL
By research site